CANNABIDIOL (has an active metabolite) | CANNABIDIOL | NATURAL MOLECULE (link) ATC N03AX24
NERVOUS SYSTEM TREATMENT OF SEIZURES ASSOCIATED WITH LENNOX-GASTAUT SYNDROME OR DRAVET SYNDROME ANTICONVULSANT AGONIST OF CANNABINOID (CB) RECEPTORS | ORAL | Tmax 3.75 HOUR VD 31906 LITER PPB 94 PERCENT Cl 1111 LITER / HOUR HT 58.5 HOUR SOLUBILITY INSOLUBLE IN WATER | CANNABINOID RECEPTOR PDB 6U8A (CBD-BOUND FULL-LENGTH RAT TRPV2 IN NANODISCS, STATE 1) LIGAND CODE = P0T (link to the list of PDB complexes) Download experimental 3D coordinates of P0T with added hydrogens | Transient receptor potential cation channel subfamily V member 1 UNIPROT Q8NER1 TRPV1 -- G-protein coupled receptor 55 UNIPROT Q9Y2T6 GPR55 more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |
M CANNABIDIOL (is an active metabolite) | CANNABIDIOL | ATC N03AX24
NERVOUS SYSTEM TREATMENT OF SEIZURES ASSOCIATED WITH LENNOX-GASTAUT SYNDROME OR DRAVET SYNDROME ANTICONVULSANT AGONIST OF CANNABINOID (CB) RECEPTORS | - | | CANNABINOID RECEPTOR | Transient receptor potential cation channel subfamily V member 1 UNIPROT Q8NER1 TRPV1 -- G-protein coupled receptor 55 UNIPROT Q9Y2T6 GPR55 more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |